charles shepherd
Senior Member
- Messages
- 2,239
NICE GUIDELINE ON ME/CFS WILL BE UPDATED!
PUBLISHED TODAY ON THE NICE GUIDELINE WEBSITE:
Surveillance report 2017 – Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management (2007) NICE guideline CG53
Surveillance decision
We will plan a full update with a modified scope of the guideline on chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy) (NICE guideline CG53).
appendix A: pre-consultation summary of evidence from surveillance).
Following a stakeholder consultation on the proposal to not update the guideline, broader issues with the guideline were highlighted that called into question the guideline scope and its current relevance.
After further consideration of information from stakeholders including:
new evidence (see appendix B: summary of evidence highlighted to NICE during consultation,
and appendix C: stakeholder consultation comments table)
alongside the evidence identified through the surveillance review,
NICE has decided to fully update the guideline with a modified scope.
how we made the decision for further information.
This page was last updated: 20 September 2017
Dr Charles Shepherd
Hon Medical Adviser, MEA
PUBLISHED TODAY ON THE NICE GUIDELINE WEBSITE:
Surveillance report 2017 – Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management (2007) NICE guideline CG53
Surveillance decision
We will plan a full update with a modified scope of the guideline on chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy) (NICE guideline CG53).
appendix A: pre-consultation summary of evidence from surveillance).
Following a stakeholder consultation on the proposal to not update the guideline, broader issues with the guideline were highlighted that called into question the guideline scope and its current relevance.
After further consideration of information from stakeholders including:
new evidence (see appendix B: summary of evidence highlighted to NICE during consultation,
and appendix C: stakeholder consultation comments table)
alongside the evidence identified through the surveillance review,
NICE has decided to fully update the guideline with a modified scope.
how we made the decision for further information.
This page was last updated: 20 September 2017
Dr Charles Shepherd
Hon Medical Adviser, MEA